scispace - formally typeset
P

P. Vignali

Publications -  11
Citations -  47

P. Vignali is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 11 publications receiving 47 citations.

Papers
More filters
Journal ArticleDOI

Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response

TL;DR: In this paper , the authors detected the SARS-CoV-2 genome in the adipose tissue of 13/23 (56%) cases of the COVID-19 cohort, showing that the virus may directly infect the parenchymal cells of subcutaneous fat.
Journal ArticleDOI

Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center

TL;DR: Despite the well-established clinical indolence of NIFTP, a careful monitoring of the contralateral lobe should not be excluded and no clinical-pathological differences can be observed between solitary and “multifocal” NifTPs.
Journal ArticleDOI

Autopsy study of testicles in covid-19: upregulation of immune-related genes and downregulation of testis-specific genes

TL;DR: Viral infection associates with activation of interferon pathways and downregulation of testis-specific genes involved in spermatogenesis in lethal COVID-19 cases and the impact of virus on fertility should be further investigated.
Journal ArticleDOI

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma

TL;DR: The largest mono-institutional series of PTC with hobnail areas and HVPTC was gathered to evaluate differences in terms of pathological features of aggressiveness, molecular profile, and treatment outcome.
Journal ArticleDOI

Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma

TL;DR: A screening based on IHC analysis showed limited sensitivity and specificity in the identification of NTRK-rearranged tumors, and alternative detection strategies should be considered for thyroid cancer.